Impact of Radiomic and Artificial Intelligence on Colorectal Cancer: A Narrative Review
Source abstract
Abstract
Colorectal cancer (CRC) remains one of the leading causes of cancer-related morbidity and mortality worldwide, representing a major public health challenge. Despite advances in screening strategies, surgical techniques, and systemic therapies, patient prognosis is often compromised by late diagnosis, tumor heterogeneity, and therapeutic resistance. In recent years, the integration of advanced imaging analytics and artificial intelligence (AI) has opened new avenues for precision oncology. Radiomics, defined as the high-throughput extraction of quantitative features from medical images, has emerged as a promising tool to capture intratumoral heterogeneity and predict clinical outcomes in a non-invasive manner. When combined with AI, particularly machine learning and deep learning approaches, radiomics enables the development of predictive and prognostic models that may support treatment personalization. This narrative review provides a comprehensive overview of CRC epidemiology and risk factors, summarizes current diagnostic and clinical management strategies, and focuses extensively on radiomics and AI applications in CRC, including workflow standardization, feature extraction, clinical applications, and challenges for implementation in daily practice.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Radiomics and Machine Learning in Medical Imaging · Artificial Intelligence in Healthcare and Education · AI in cancer detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Experimental and Clinical Medicine, University “Magna Graecia”, Viale Europa, 88100 Catanzaro, Italy
Department of Health Sciences, University “Magna Graecia”, 88100 Catanzaro, Italy
Radiology Unit, Pugliese-Ciaccio, Renato Dulbecco University Hospital, 88100 Catanzaro, Italy
References (99)
Show source-provided references
1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Global patterns and trends in colorectal cancer incidence and mortality10.1136/gutjnl-2015-310912 ↗
3. Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors
4. Thanikachalam, K., and Khan, G. (2019). Colorectal cancer and nutrition. Nutrients, 11.10.3390/nu11010164 ↗
5. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: Systematic review and dose-response meta-analysis of prospective studies10.1136/bmj.i2716 ↗
6. Calcium intake and colorectal cancer risk: Results from the nurses’ health study and health professionals follow-up study10.1002/ijc.30293 ↗
7. Cancers complicating inflammatory bowel disease10.1056/NEJMra1403718 ↗
8. ACG clinical guidelines: Colorectal cancer screening 202110.14309/ajg.0000000000001122 ↗
9. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening
10. Clinical management of metastatic colorectal cancer in the era of precision medicine
11. Management of BRAF-mutant metastatic colorectal cancer: A review of treatment options and evidence-based guidelines10.1016/j.annonc.2021.03.206 ↗
12. Microsatellite instability in colorectal cancer10.1053/j.gastro.2009.12.064 ↗
13. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: A systematic review and meta-analysis10.1148/radiol.13122833 ↗
14. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer10.1002/bjs.8702 ↗
15. Radiomics: Extracting more information from medical images using advanced feature analysis10.1016/j.ejca.2011.11.036 ↗
16. Radiomics: Images are more than pictures, they are data10.1148/radiol.2015151169 ↗
17. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach10.1038/ncomms5006 ↗
18. Radiomics: The bridge between medical imaging and personalized medicine10.1038/nrclinonc.2017.141 ↗
19. Colorectal Cancer: Epidemiology, Risk Factors, and Public Health Strategies10.1159/000543921 ↗
20. Accruing evidence on benefits of adherence to the Mediterranean diet on health: An updated systematic review and meta-analysis10.3945/ajcn.2010.29673 ↗
21. A review of human carcinogens—Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish10.1016/S1470-2045(09)70326-2 ↗
22. Hereditary and familial colon cancer10.1053/j.gastro.2010.01.054 ↗
23. Laparoscopic-assisted proctocolectomy with prolapsing technique for familial adenomatous polyposis10.1097/SLE.0b013e3182a4bfcb ↗
24. Risk of colorectal cancer in patients with ulcerative colitis: A meta-analysis of population-based cohort studies10.1016/j.cgh.2012.01.010 ↗
25. Lessons from hereditary colorectal cancer10.1016/S0092-8674(00)81333-1 ↗
26. Hereditary colorectal cancer10.1056/NEJMra012242 ↗
27. Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas10.1001/jama.2012.8780 ↗
28. Multitarget stool DNA testing for colorectal cancer screening10.1056/NEJMoa1311194 ↗
29. A cell-free DNA blood-based test for colorectal cancer screening10.1056/NEJMoa2304714 ↗
30. Current and future perspectives of liquid biopsies in genomics-driven oncology10.1038/s41576-018-0071-5 ↗
31. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging
32. Magnetic resonance imaging for the clinical management of rectal cancer patients: Recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting10.1007/s00330-013-2864-4 ↗
33. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer10.1200/JCO.1999.17.3.894 ↗
34. Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data10.1016/S1470-2045(10)70172-8 ↗
35. Quasar Collaborative Group (2007). Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomized study. Lancet, 370, 2020–2029.10.1016/S0140-6736(07)61866-2 ↗
36. Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial10.1200/JCO.22.00046 ↗
37. Precision medicine for metastatic colorectal cancer: An evolving era10.1080/17474124.2019.1663174 ↗
38. The Image Biomarker Standardization Initiative: Standardized quantitative radiomics for High-Throughput Image-based Phenotyping10.1148/radiol.2020191145 ↗
39. Emerging applications of radiomics in rectal cancer: State of the art and future perspectives10.3748/wjg.v27.i25.3802 ↗
40. Radiomics: The process and the challenges10.1016/j.mri.2012.06.010 ↗
41. The Rise of Radiomics and Implications for Oncologic Management10.1093/jnci/djx055 ↗
42. A deep look into radiomics10.1007/s11547-021-01389-x ↗
43. A review in radiomics: Making personalized medicine a reality via routine imaging10.1002/med.21846 ↗
44. Quantitative radiomics studies for tissue characterization: Review of technology and methodology10.1259/bjr.20160665 ↗
45. Metrology Standards for Quantitative Imaging Biomarkers10.1148/radiol.2015142202 ↗
46. Introduction to Radiomics10.2967/jnumed.118.222893 ↗
47. Computational Radiomics System to Decode the Radiographic Phenotype10.1158/0008-5472.CAN-17-0339 ↗
48. 3D Slicer as an image computing platform for the Quantitative Imaging Network10.1016/j.mri.2012.05.001 ↗
49. Kayalibay, B., Jensen, G., and van der Smagt, P. (2017). CNN-based segmentation of medical imaging data. arXiv.
50. Parmar, C., Rios Velazquez, E., Leijenaar, R., Jermoumi, M., Carvalho, S., Mak, R.H., Mitra, S., Shankar, B.U., Kikinis, R., and Haibe-Kains, B. (2014). Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS ONE, 9.10.1371/journal.pone.0102107 ↗
51. Wang, J., Liu, X., Dong, D., Song, J., Xu, M., Zang, Y., and Tian, J. (2016, January 16–20). Prediction of malignant and benign of lung tumor using a quantitative radiomic method. Proceedings of the 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Orlando, FL, USA.10.1109/EMBC.2016.7590938 ↗
52. Texture Analysis and Its Applications in Biomedical Imaging: A Survey10.1109/RBME.2021.3115703 ↗
53. Textural features for image classification10.1109/TSMC.1973.4309314 ↗
54. Textural features corresponding to textural properties10.1109/21.44046 ↗
55. Three-dimensional solid texture analysis in biomedical imaging: Review and opportunities10.1016/j.media.2013.10.005 ↗
56. Bellman, R. (1961). Adaptive Control Processes: A Guided Tour, Princeton University Press.10.1515/9781400874668 ↗
57. An introduction to variable and feature selection
58. Regression shrinkage and selection via the LASSO10.1111/j.2517-6161.1996.tb02080.x ↗
59. SMOTE: Synthetic minority over-sampling technique10.1613/jair.953 ↗
60. Multidimensional and fuzzy sample entropy (SampEnMF) for quantifying H&E histological images of colorectal cancer10.1016/j.compbiomed.2018.10.013 ↗
61. Machine learning applications in cancer prognosis and prediction10.1016/j.csbj.2014.11.005 ↗
62. Radiomics with artificial intelligence: A practical guide for beginners10.5152/dir.2019.19321 ↗
63. Vapnik, V.N. (1995). The Nature of Statistical Learning Theory, Springer.10.1007/978-1-4757-2440-0 ↗
64. Regularization and variable selection via the elastic net10.1111/j.1467-9868.2005.00503.x ↗
65. Deep learning10.1038/nature14539 ↗
66. Selvaraju, R.R., Cogswell, M., Das, A., Vedantam, R., Parikh, D., and Batra, D. (2017, January 22–29). Grad-CAM: Visual explanations from deep networks via gradient-based localization. Proceedings of the IEEE International Conference on Computer Vision, Venice, Italy.10.1109/ICCV.2017.74 ↗
67. MRI radiomics in the prediction of therapeutic response to neoadjuvant therapy for locoregionally advanced rectal cancer: A systematic review10.1080/14737140.2021.1860762 ↗
68. MR Imaging of Rectal Cancer: Radiomics Analysis to Assess Treatment Response after Neoadjuvant Therapy10.1148/radiol.2018172300 ↗
69. Machine learning in predicting pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer using MRI: A systematic review and meta-analysis10.1093/bjr/tqae098 ↗
70. Identification and validation of a machine learning model of complete response to radiation in rectal cancer reveals immune infiltrate and TGFβ as key predictors10.1016/j.ebiom.2024.105228 ↗
71. A radiomics-based artificial intelligence model to assess the risk of relapse in localized colon cancer10.1016/j.esmoop.2025.105495 ↗
72. Prognostic value of MRI in assessing extramural venous invasion in rectal cancer: Multi-readers’ diagnostic performance10.1007/s00330-018-5926-9 ↗
73. Pretreatment MR-based radiomics nomogram as potential imaging biomarker for individualized assessment of perineural invasion status in rectal cancer10.1007/s00261-020-02710-4 ↗
74. MRI-based Radiomics nomogram to detect primary rectal cancer with synchronous liver metastases10.1038/s41598-019-39651-y ↗
75. MRI-based radiomics nomogram to predict synchronous liver metastasis in primary rectal cancer patients10.1002/cam4.3185 ↗
76. Whole liver CT texture analysis to predict the development of colorectal liver metastases-A multicentre study10.1016/j.ejrad.2017.04.019 ↗
77. Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer10.1007/s00330-018-5763-x ↗
78. The value of intravoxel incoherent motion diffusion-weighted imaging in predicting the pathologic response to neoadjuvant chemotherapy in locally advanced esophageal squamous cell carcinoma10.1007/s00330-020-07248-z ↗
79. Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer10.4143/crt.2019.050 ↗
80. Radiomics Response Signature for Identification of Metastatic Colorectal Cancer Sensitive to Therapies Targeting EGFR Pathway10.1093/jnci/djaa017 ↗
81. Giannini, V., Pusceddu, L., Defeudis, A., Nicoletti, G., Cappello, G., Mazzetti, S., Sartore-Bianchi, A., Siena, S., Vanzulli, A., and Rizzetto, F. (2022). Delta-Radiomics Predicts Response to First-Line Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients with Liver Metastases. Cancers, 14.10.3390/cancers14010241 ↗
82. Delta radiomics: A systematic review10.1007/s11547-021-01436-7 ↗
83. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer10.1158/1078-0432.CCR-17-1038 ↗
84. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer10.1007/s00330-018-5683-9 ↗
85. Radiomics for differentiating tumor deposits from lymph node metastasis in rectal cancer10.3748/wjg.v28.i29.3960 ↗
86. Multiparameter MRI-based radiomics for preoperative prediction of extramural venous invasion in rectal cancer10.1007/s00330-021-08242-9 ↗
87. Comparative study of radiomics, tumor morphology, and clinicopathological factors in predicting overall survival of patients with rectal cancer before surgery10.1016/j.tranon.2022.101352 ↗
88. The impact of the variation of imaging parameters on the robustness of Computed Tomography radiomic features: A review10.1016/j.compbiomed.2021.104400 ↗
89. Sensitivity of standardised radiomics algorithms to mask generation across different software platforms10.1038/s41598-023-41475-w ↗
90. Application research of radiomics in colorectal cancer: A bibliometric study10.1097/MD.0000000000037827 ↗
91. Radiomics and the Image Biomarker Standardisation Initiative (IBSI): A Narrative Review Using a Six-Question Map and Implementation Framework for Reproducible Imaging Biomarkers
92. Explainable AI: The new 42?
93. Samek, W., Wiegand, T., and Müller, K.R. (2017). Explainable artificial intelligence: Understanding, visualizing, and interpreting deep learning models. arXiv.
94. Quo vadis Radiomics? Bibliometric analysis of 10-year Radiomics journey10.1007/s00330-023-09645-6 ↗
95. Aida, S., Okugawa, J., Fujisaka, S., Kasai, T., Kameda, H., and Sugiyama, T. (2020). Deep Learning of Cancer Stem Cell Morphology Using Conditional Generative Adversarial Networks. Biomolecules, 10.10.3390/biom10060931 ↗
96. The potential of radiomic biomarkers to guide precision medicine in oncology10.1001/jamaoncol.2016.2631 ↗
97. Radiomics: Principles and radiotherapy applications10.1016/j.critrevonc.2019.03.015 ↗
98. Artificial intelligence in gastroenterology—Promises and limits10.15403/jgld-5824 ↗
99. Abenavoli, L., Scarlata, G.G.M., Gambardella, M.L., Battaglia, C., Borelli, M., Manti, F., and Laganà, D. (2025). Combined model for the diagnosis of hepatocellular carcinoma: A pilot study comparing the liver to spleen volume ratio and liver vein to cava attenuation. J. Clin. Med., 14.10.20944/preprints202505.1902.v1 ↗